Concentration-dependent bimodal effect of specific 18 kDa translocator protein (TSPO) ligands on cell death processes induced by ammonium chloride: potential implications for neuropathological effects due to hyperammonemia

CNS Neurol Disord Drug Targets. 2014;13(4):574-92. doi: 10.2174/18715273113126660194.

Abstract

The role of the 18-kDa Translocator Protein (TSPO) in cell death induced by NH4Cl (1-50 mM) for 24-72 hours to human glioblastoma U118MG cells was investigated. Cell death was already observed after 48 hours of treatment with NH4Cl at 5 mM. Dose and time-responses curves indicated that 15 mM of NH4Cl applied for 72 hours was the optimal condition for our viability assays. For example, 72 hours of 15 mM of NH4Cl caused a 50.3% increase in propidium iodide uptake, and lactate dehydrogenase release was 41.2% of the positive control, indicating significant increases in cell death. Furthermore, compared to vehicle control, these experimental conditions resulted in a significant decrease of 44.9% of the mitochondrial activity, a 62.3% increase in incidence of collapse of mitochondrial membrane potential, and an increase of 49.0% of cardiolipin peroxidation. In addition, a significant 4.3 fold increase in the maximal binding capacity (Bmax) of TSPO was found in NH4Cl-exposed cells. Surprisingly, western blot analysis and real-time PCR did not demonstrate changes in TSPO expression. We also found that neither NH4Cl nor glutamine (a metabolic product of enhanced NH4Cl levels) inhibited binding of the TSPO ligand [(3)H]PK 11195. Interestingly, we observed a bimodal effect of the TSPO ligands PK 11195, Ro5-4864, and FGIN-1-27 on the toxicity of NH4Cl; such that 1-100 nM concentrations of TSPO ligands were protective, while concentrations above 1 μM enhanced NH4Cl-induced cell death processes. In conclusion, TSPO takes part in a bimodal way in the lethal effects induced by NH4Cl in glial type cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ammonium Chloride / toxicity*
  • Benzodiazepinones / pharmacology
  • Cardiolipins / metabolism
  • Cell Death / drug effects*
  • Cell Death / physiology*
  • Cell Line, Tumor
  • Cell Shape
  • Dose-Response Relationship, Drug
  • GABA Agents / pharmacology
  • Glutamine / metabolism
  • Humans
  • Hyperammonemia / chemically induced
  • Hyperammonemia / drug therapy
  • Hyperammonemia / physiopathology*
  • Indoleacetic Acids / pharmacology
  • Isoquinolines / metabolism
  • Isoquinolines / pharmacology
  • L-Lactate Dehydrogenase / metabolism
  • Ligands
  • Lipid Peroxidation / drug effects
  • Membrane Potential, Mitochondrial / drug effects
  • Membrane Potential, Mitochondrial / physiology
  • Mitochondria / drug effects
  • Mitochondria / physiology
  • Neuroprotective Agents / pharmacology
  • Propidium / chemistry
  • Receptors, GABA / metabolism*

Substances

  • Benzodiazepinones
  • Cardiolipins
  • GABA Agents
  • Indoleacetic Acids
  • Isoquinolines
  • Ligands
  • Neuroprotective Agents
  • Receptors, GABA
  • TSPO protein, human
  • Ammonium Chloride
  • Glutamine
  • N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
  • 4'-chlorodiazepam
  • Propidium
  • L-Lactate Dehydrogenase
  • PK 11195